Axxam S.P.A.
Records under this name other than patents Axxam S.P.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,718,812 | Substituted thiazole or oxazole P2X7 receptor antagonists Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,167,281 | Substituted thiazole or oxazole P2X7 receptor antagonists Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,669,267 | Substituted N-[2-(4-phenoxypiperidin-1-yl)-2-(1,3-thiazol-5-yl)ethyl]benzamide and N-[2-(4-benzyloxypiperidin-1-yl)-2-(1,3-thiazol-5-yl)ethyl]benzamide derivatives P2X7 receptor antagonists Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,597,702 | Substituted Pyrazoles FFA4/GPR120 Receptor Agonists Formerly held In force · High confidence | In force | High confidence | |
| US 11,623,919 | Heterocyclic P2X7 Antagonists Formerly held In force · High confidence | In force | High confidence | |
| US 11,155,538 | Bicyclic CX3CR1 Receptor Agonists Formerly held In force · High confidence | In force | High confidence | |
| US 11,958,839 | Bicyclic CX3CR1 Receptor Agonists Formerly held In force · High confidence | In force | High confidence | |
| US 12,258,337 | Bicyclic CX3CR1 Receptor Agonists Formerly held In force · High confidence | In force | High confidence | |
| US 12,098,145 | Oxazole TRPML1 agonists and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,833,749 | Isolated photoprotein mtClytin, and use thereof Term ended Term ended Aug 24, 2026 · USPTO record | Term ended | Term ended Aug 24, 2026 | USPTO record |